The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.
Affiliation
Division of Clinical Pharmacology, United Medical School, Guy's Hospital, London.Issue Date
1991-01
Metadata
Show full item recordAbstract
1. We investigated the pharmacokinetics of ifosfamide 5 g m-2 given by two regimens. Six patients (one female), median age 55 (range 40-71) years, all with lung cancer received 5 g m-2 ifosfamide (median ifosfamide dose 8.95 g) as an intravenous infusion over 0.5 h with mesna. Four other cancer patients (all male) of median age 52.5 (range 23-72) years were studied on seven treatment occasions with 5 g m-2 ifosfamide (median ifosfamide dose 8.88 g) as a 24 h intravenous infusion with mesna. Plasma was assayed for ifosfamide by gas liquid chromatography and for alkylating activity by the nitrobenzylpyridine method. 2. After ifosfamide 5 g m-2 infused over 0.5 h, the decay of the plasma ifosfamide concentration was monoexponential with a median (range) t1/2,z of 5.4 h (3.6-10.4 h). The median clearance was 60 ml min-1 (47-104) and the median volume of distribution was 388 (329-783) ml kg-1. Plasma nitrobenzylpyridine alkylating activity showed a biexponential decay in four patients and a monoexponential decay in two, with a median AUC of 102 (24-177) nmol nor nitrogen mustard eq h ml-1. 3. When ifosfamide 5 g m-2 was given as a 24 h infusion, the decay of the plasma ifosfamide concentration was monoexponential, the median (range) t1/2,z was 4.5 (3.4-6.1), the median volume of distribution was 563 (292-818) ml kg-1 and the median clearance was 79 (59-116) ml min-1. Plasma nitrobenzylpyridine alkylating activity decayed monoexponentially and the median AUC was 49 (45-131) nmol nor nitrogen mustard eq ml-1 h.(ABSTRACT TRUNCATED AT 250 WORDS)Citation
The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients. 1991, 31 (1):77-82 Br J Clin PharmacolJournal
British Journal of Clinical PharmacologyPubMed ID
2015174Type
ArticleLanguage
enISSN
0306-5251Collections
Related articles
- Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism.
- Authors: Lewis LD, Fitzgerald DL, Harper PG, Rogers HJ
- Issue date: 1990 Nov
- Alkylating activity in serum, urine, and CSF following high-dose ifosfamide in children.
- Authors: Ninane J, Baurain R, de Kraker J, Ferster A, Trouet A, Cornu G
- Issue date: 1989
- Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
- Authors: Pendyala L, Creaven PJ, Schwartz G, Meropol NJ, Bolanowska-Higdon W, Zdanowicz J, Murphy M, Perez R
- Issue date: 2000 Apr
- A study of 5 day fractionated ifosfamide pharmacokinetics in consecutive treatment cycles.
- Authors: Lewis LD
- Issue date: 1996 Aug
- A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies.
- Authors: Lopez AM, Ketchum M, Nichols H, Xu MJ, Peng YM, Dorr R, Alberts DS
- Issue date: 2000